Usefulness of using pure β-TCP bone substitute (Neobone) in post-orthopedic implant removal procedures
PLOS One · 2025
DOI: 10.1371/journal.pone.0336404 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Jeong Eun Moon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nursing Department, Honam University, Gwangju, Republic of Korea. Hauptthemen laut MEDLINE: Calcium Phosphates, Bone Substitutes, Device Removal, Orthopedic Procedures. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
The orthopedic implant removal procedure is one of the most commonly performed orthopedic surgeries. This study aimed to compare and report the clinical outcomes between patients who underwent only curettage and those who received pure β-TCP (Neobone ® ) following curettage.
Methods
Between January 1, 2018, and December 31, 2023, patients at our hospital who underwent implant removal and could be followed for over a year were included in the study. The study encompassed 77 cases.
Results
The cohort comprised 40 males (51.9%) and 37 females (48.1%) with an average age of 32.5 ± 21.2 years (range 8–69). There were no significant differences between the groups in terms of sex, age, the interval between the first operation and the orthopedic implant removal procedure, locations of operations, or the orthopedic fixation techniques used initially. However, the group undergoing implant removal with β-TCP (Neobone ® ) bone graft showed statistically significant improvements in performing scar revision procedures simultaneously and in not requiring drain insertion (p = .000).
Conclusions
Compared to the group that only underwent curettage, the group treated with pure β-TCP (Neobone ® ) bone graft required fewer drain placements and more often performed scar revisions simultaneously, facilitating faster healing. While there was no difference in the period for ROM exercises or weight bearing, no refractures occurred in the β-TCP bone substitute group. Hence, the application of pure β-TCP (Neobone ® ) is clinically advantageous.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Nursing Department, Honam University, Gwangju, Republic of Korea.
- Department of Medical Science, College of Medicine, Chosun University Graduate School, Gwangju, Republic of Korea.
- Department of Orthopedic Surgery, Chosun University Hospital, Gwangju, Republic of Korea.
ORCID-Profile: Yong Jin Cho
Zitieren
APA
Moon, J. E., Cho, Y. M., Lee, G. C., & Cho, Y. J. (2025). Usefulness of using pure β-TCP bone substitute (Neobone) in post-orthopedic implant removal procedures. PLOS One. https://doi.org/10.1371/journal.pone.0336404
Vancouver
Moon JE, Cho YM, Lee GC, Cho YJ. Usefulness of using pure β-TCP bone substitute (Neobone) in post-orthopedic implant removal procedures. PLOS One. 2025. doi:10.1371/journal.pone.0336404
BibTeX
@article{Moon2025,
author = {Moon, Jeong Eun and Cho, Young Min and Lee, Gwang Chul and Cho, Yong Jin},
title = {Usefulness of using pure β-TCP bone substitute (Neobone) in post-orthopedic implant removal procedures},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0336404}
}
EUVIMED